St. Louis: ApoE Receptors—Hold Sway Over Synaptic Function St. Louis: ApoE—Receptors, Theories and Therapies St. Louis: ApoE—A Clearer View of its Role In AD? The apolipoprotein E gene is the strongest genetic risk factor for late-onset Alzheimer disease.
It failed in the large Ginkgo of Memory (GEM) prevention trial, but companies are still betting ginkgo biloba extract is a valuable anti-dementia agent...
A potential therapeutic strategy for Alzheimer disease (AD) is to inhibit the BACE enzymes that kickstart processing of amyloid precursor protein (APP) to form Aβ...
During the late 1980s and the 1990s, tissue grafts, chosen to replace lost dopaminergic neurons, seemed to show great promise for the treatment of Parkinson disease...
Sifting through the genome has netted several mutations responsible for motor neuron diseases, but scientists still cannot explain the cause for most incidences...
Bethesda: Dawn of the Epigenetics Era Bethesda: The Methylated Brain Bethesda: "Ome" Sweet "Ome"—Epigenome Joins Genome, Proteome Epigenetics, the "software" that interprets information stored in the DNA "hardware,"